{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:20:41Z","timestamp":1781886041917,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11064-020-03130-y","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T23:14:24Z","timestamp":1600298064000},"page":"2786-2799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Della Grace Thomas","family":"Parambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ajmal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareeha","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Manzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqsa","family":"Itzaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Harilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":false,"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"3130_CR1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL et al (2003) Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol 157:1015\u20131022","journal-title":"Am J Epidemiol"},{"key":"3130_CR2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG et al (2010) Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med 16:653\u2013661","journal-title":"Nat Med"},{"key":"3130_CR3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.39289.437454.AD","volume":"335","author":"CE Clarke","year":"2007","unstructured":"Clarke CE (2007) Clinical review-Parkinson\u2019s disease. BMJ Br Med J Int Ed 335:441\u2013444","journal-title":"BMJ Br Med J Int Ed"},{"key":"3130_CR4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh FN, Surguchov A (2018) Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front Neurosci 12:612","journal-title":"Front Neurosci"},{"key":"3130_CR5","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.2174\/1381612820666140305224545","volume":"20","author":"A Yadav","year":"2014","unstructured":"Yadav A, Agarwal S, Kant Tiwari S, Chaturvedi K, R, (2014) Mitochondria: prospective targets for neuroprotection in Parkinson\u2019s disease. Curr Pharm Des 20:5558\u20135573","journal-title":"Curr Pharm Des"},{"key":"3130_CR6","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","volume":"27","author":"JM Ellis","year":"2017","unstructured":"Ellis JM, Fell MJ (2017) Current approaches to the treatment of Parkinson\u2019s disease. Bioorg Med Chem Lett 27:4247\u20134255","journal-title":"Bioorg Med Chem Lett"},{"key":"3130_CR7","doi-asserted-by":"crossref","first-page":"1900177","DOI":"10.1002\/ardp.201900177","volume":"352","author":"B Mathew","year":"2019","unstructured":"Mathew B, Parambi DG, Mathew GE et al (2019) Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer\u2019s and Parkinson\u2019s diseases. Arch Pharm (Weinheim) 352:1900177","journal-title":"Arch Pharm (Weinheim)"},{"key":"3130_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40263-015-0249-8","volume":"29","author":"D Robakis","year":"2015","unstructured":"Robakis D, Fahn S (2015) Defining the role of the monoamine oxidase-B inhibitors for Parkinson\u2019s disease. CNS Drugs 29:433\u2013441","journal-title":"CNS Drugs"},{"key":"3130_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40263-017-0408-1","volume":"31","author":"HA Blair","year":"2017","unstructured":"Blair HA, Dhillon S (2017) Safinamide: a review in Parkinson\u2019s disease. CNS Drugs 31:169\u2013176","journal-title":"CNS Drugs"},{"key":"3130_CR10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cdc.2018.10.009","volume":"17","author":"M Joy","year":"2018","unstructured":"Joy M, Mathew B, Sudarsanakumar C (2018) Structural features of Safinamide: a combined Hirshfeld surface analysis & quantum chemical treatment. Chem Data Collect 17:404\u2013414","journal-title":"Chem Data Collect"},{"key":"3130_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejphar.2017.10.023","volume":"818","author":"HH Chan","year":"2018","unstructured":"Chan HH, Tse MK, Kumar S, Zhuo L (2018) A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties. Eur J Pharmacol 818:254\u2013262","journal-title":"Eur J Pharmacol"},{"key":"3130_CR12","doi-asserted-by":"crossref","first-page":"104612","DOI":"10.1016\/j.neuint.2019.104612","volume":"132","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Pyrgelis E-S, Piperi C (2020) Neuroprotective potential of chrysin in Parkinson\u2019s disease: molecular mechanisms and clinical implications. Neurochem Int 132:104612","journal-title":"Neurochem Int"},{"key":"3130_CR13","doi-asserted-by":"crossref","first-page":"111770","DOI":"10.1016\/j.ejmech.2019.111770","volume":"185","author":"D Chavarria","year":"2020","unstructured":"Chavarria D, Fernandes C, Silva V et al (2020) Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: structure-activity-toxicity, drug-likeness and efflux transport studies. Eur J Med Chem 185:111770","journal-title":"Eur J Med Chem"},{"key":"3130_CR14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bioorg.2015.07.001","volume":"62","author":"B Mathew","year":"2015","unstructured":"Mathew B, Mathew GE, U\u00e7ar G et al (2015) Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: synthesis, biochemistry and molecular docking studies. Bioorg Chem 62:22\u201329","journal-title":"Bioorg Chem"},{"key":"3130_CR15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/1570178612666150903213416","volume":"12","author":"B Mathew","year":"2015","unstructured":"Mathew B, Ucar G, Yabanogclu-Ciftci S et al (2015) Development of fluorinated thienylchalcones as monoamine oxidase-b inhibitors: design, synthesis, biological evaluation and molecular docking studies. Lett Org Chem 12:605\u2013613","journal-title":"Lett Org Chem"},{"key":"3130_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1871524915666151002124443","volume":"16","author":"B Mathew","year":"2016","unstructured":"Mathew B, Haridas A, Suresh J et al (2016) Monoamine oxidase inhibitory action of chalcones: a mini review. Cent Nerv Syst Agents Med Chem 16:120\u2013136","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"3130_CR17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/cbdv.201500367","volume":"13","author":"B Mathew","year":"2016","unstructured":"Mathew B, Mathew GE, U\u00e7ar G et al (2016) Potent and selective monoamine oxidase-B inhibitory activity: Fluoro-vs. Trifluoromethyl-4-hydroxylated chalcone derivatives. Chem Biodivers 13:1046\u20131052","journal-title":"Chem Biodivers"},{"key":"3130_CR18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijbiomac.2016.05.110","volume":"91","author":"B Mathew","year":"2016","unstructured":"Mathew B, Haridas A, U\u00e7ar G et al (2016) Exploration of chlorinated thienyl chalcones: a new class of monoamine oxidase-B inhibitors. Int J Biol Macromol 91:680\u2013695","journal-title":"Int J Biol Macromol"},{"key":"3130_CR19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cmdc.201600122","volume":"11","author":"B Mathew","year":"2016","unstructured":"Mathew B, Haridas A, U\u00e7ar G et al (2016) Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: a new class of reversible MAO-B inhibitors. ChemMedChem 11:1161\u20131171","journal-title":"ChemMedChem"},{"key":"3130_CR20","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/cmdc.201600497","volume":"11","author":"B Mathew","year":"2016","unstructured":"Mathew B, U\u00e7ar G, Mathew GE et al (2016) Monoamine oxidase inhibitory activity: methyl-versus chlorochalcone derivatives. ChemMedChem 11:2649\u20132655","journal-title":"ChemMedChem"},{"key":"3130_CR21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ardp.201600088","volume":"349","author":"R Sasidharan","year":"2016","unstructured":"Sasidharan R, Manju SL, U\u00e7ar G et al (2016) Identification of indole-based chalcones: discovery of a potent, selective, and reversible class of MAO-B inhibitors. Arch Pharm (Weinheim) 349:627\u2013637","journal-title":"Arch Pharm (Weinheim)"},{"key":"3130_CR22","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1002\/slct.201702141","volume":"2","author":"B Mathew","year":"2017","unstructured":"Mathew B, U\u00e7ar G, Rapheal C et al (2017) Characterization of thienylchalcones as hMAO-B inhibitors: synthesis, biochemistry and molecular dynamics studies. ChemistrySelect 2:11113\u201311119","journal-title":"ChemistrySelect"},{"key":"3130_CR23","doi-asserted-by":"crossref","first-page":"103335","DOI":"10.1016\/j.bioorg.2019.103335","volume":"93","author":"DGT Parambi","year":"2019","unstructured":"Parambi DGT, Oh JM, Baek SC et al (2019) Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. Bioorg Chem 93:103335","journal-title":"Bioorg Chem"},{"key":"3130_CR24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12906-019-2772-5","volume":"19","author":"U Saleem","year":"2019","unstructured":"Saleem U, Raza Z, Anwar F et al (2019) Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson\u2019s disease. BMC Complement Altern Med 19:352","journal-title":"BMC Complement Altern Med"},{"key":"3130_CR25","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S1995-7645(14)60260-1","volume":"7","author":"U Saleem","year":"2014","unstructured":"Saleem U, Ahmad B, Ahmad M et al (2014) Investigation of in vivo antioxidant activity of Euphorbia helioscopia latex and leaves methanol extract: a target against oxidative stress induced toxicity. Asian Pac J Trop Med 7:S369\u2013S375","journal-title":"Asian Pac J Trop Med"},{"key":"3130_CR26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/medicina55050192","volume":"55","author":"NT Mir","year":"2019","unstructured":"Mir NT, Saleem U, Anwar F et al (2019) Lawsonia Inermis markedly improves cognitive functions in animal models and modulate oxidative stress markers in the brain. Medicina (Mex) 55:192","journal-title":"Medicina (Mex)"},{"key":"3130_CR27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/medicina55050184","volume":"55","author":"U Saleem","year":"2019","unstructured":"Saleem U, Raza Z, Anwar F et al (2019) Experimental and computational studies to characterize and evaluate the therapeutic effect of Albizia lebbeck (L.) seeds in Alzheimer\u2019s disease. Medicina (Mex) 55:184","journal-title":"Medicina (Mex)"},{"key":"3130_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"3130_CR29","unstructured":"Rahman H, Eswaraiah MC (2008) Simple spectroscopic methods for estimating brain neurotransmitters, antioxidant enzymes of laboratory animals like mice: a review. Pharmatutor Art: 1244"},{"key":"3130_CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neurobiolaging.2005.02.017","volume":"27","author":"S Czasch","year":"2006","unstructured":"Czasch S, Paul S, Baumg\u00e4rtner W (2006) A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol Aging 27:293\u2013305","journal-title":"Neurobiol Aging"},{"key":"3130_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pbb.2013.08.009","volume":"111","author":"EY Bazhenova","year":"2013","unstructured":"Bazhenova EY, Kulikov AV, Tikhonova MA et al (2013) On the association between lipopolysaccharide induced catalepsy and serotonin metabolism in the brain of mice genetically different in the predisposition to catalepsy. Pharmacol Biochem Behav 111:71\u201375","journal-title":"Pharmacol Biochem Behav"},{"key":"3130_CR32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroscience.2013.09.064","volume":"255","author":"JG Tostes","year":"2013","unstructured":"Tostes JG, Medeiros P, Melo-Thomas L (2013) Modulation of haloperidol-induced catalepsy in rats by GABAergic neural substrate in the inferior colliculus. Neuroscience 255:212\u2013218","journal-title":"Neuroscience"},{"key":"3130_CR33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","volume":"172","author":"V Di Matteo","year":"2008","unstructured":"Di Matteo V, Pierucci M, Esposito E et al (2008) Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson\u2019s disease and other motor disorders. Prog Brain Res 172:423\u2013463","journal-title":"Prog Brain Res"},{"key":"3130_CR34","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1017\/S1461145711001696","volume":"15","author":"TJ Banasikowski","year":"2012","unstructured":"Banasikowski TJ, Beninger RJ (2012) Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors. Int J Neuropsychopharmacol 15:1525\u20131534","journal-title":"Int J Neuropsychopharmacol"},{"key":"3130_CR35","first-page":"e2376","volume":"10","author":"TN Luong","year":"2011","unstructured":"Luong TN, Carlisle HJ, Southwell A, Patterson PH (2011) Assessment of motor balance and coordination in mice using the balance beam. JoVE J Vis Exp 10:e2376","journal-title":"JoVE J Vis Exp"},{"key":"3130_CR36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0149-7634(94)90004-3","volume":"18","author":"A Cerbone","year":"1994","unstructured":"Cerbone A, Sadile AG (1994) Behavioral habituation to spatial novelty: interference and noninterference studies. Neurosci Biobehav Rev 18:497\u2013518","journal-title":"Neurosci Biobehav Rev"},{"key":"3130_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-303-9_1","volume":"42","author":"TD Gould","year":"2009","unstructured":"Gould TD, Dao DT, Kovacsics CE (2009) The open field test. Mood and anxiety related phenotypes in mice. Neuromethods 42:1\u201320","journal-title":"Neuromethods"},{"key":"3130_CR38","first-page":"571","volume":"19","author":"JR Boissier","year":"1964","unstructured":"Boissier JR, Simon P, Lwoff JM (1964) L\u2019utilisation d\u2019une r\u00e9action particuli\u00e8re de la souris (m\u00e9thode de la planche \u00e0 trous) pour l\u2019\u00e9tude des m\u00e9dicaments psychotropes. Therapie 19:571\u2013589","journal-title":"Therapie"},{"key":"3130_CR39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0753-3322(97)86248-8","volume":"52","author":"HG Vogel","year":"1998","unstructured":"Vogel HG, Vogel WH (1998) Drug discovery and evaluation. Biomed Pharmacother 52:47\u201347","journal-title":"Biomed Pharmacother"},{"key":"3130_CR40","first-page":"461","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Park Dis 3:461\u2013491","journal-title":"J Park Dis"},{"key":"3130_CR41","first-page":"1","volume":"2016","author":"S Di Meo","year":"2016","unstructured":"Di Meo S, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev 2016:1\u201344","journal-title":"Oxid Med Cell Longev"},{"key":"3130_CR42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10072-008-0986-2","volume":"29","author":"H Yokoyama","year":"2008","unstructured":"Yokoyama H, Kuroiwa H, Yano R, Araki T (2008) Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson\u2019s disease. Neurol Sci 29:293\u2013301","journal-title":"Neurol Sci"},{"key":"3130_CR43","first-page":"137","volume":"17","author":"Z Khan","year":"2018","unstructured":"Khan Z, Ali SA (2018) Oxidative stress-related biomarkers in Parkinson\u2019s disease: a systematic review and meta-analysis. Iran J Neurol 17:137","journal-title":"Iran J Neurol"},{"key":"3130_CR44","unstructured":"Triarhou LC (2013) Dopamine and Parkinson\u2019s disease. In: Madame Curie bioscience database [Internet]. Landes Bioscience, Austin, TX"},{"key":"3130_CR45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","volume":"5","author":"C Delaville","year":"2011","unstructured":"Delaville C, De Deurwaerd\u00e8re P, Benazzouz A (2011) Noradrenaline and Parkinson\u2019s disease. Front Syst Neurosci 5:31","journal-title":"Front Syst Neurosci"},{"key":"3130_CR46","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1100\/2011\/172893","volume":"11","author":"M Politis","year":"2011","unstructured":"Politis M, Loane C (2011) Serotonergic dysfunction in Parkinson\u2019s disease and its relevance to disability. Sci World J 11:1726\u20131734","journal-title":"Sci World J"},{"key":"3130_CR47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Politis","year":"2015","unstructured":"Politis M, Niccolini F (2015) Serotonin in Parkinson\u2019s disease. Behav Brain Res 277:136\u2013145","journal-title":"Behav Brain Res"},{"key":"3130_CR48","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1590\/S0100-879X2005001200015","volume":"38","author":"JGP Pires","year":"2005","unstructured":"Pires JGP, Bonikovski V, Futuro-Neto HA (2005) Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice. Braz J Med Biol Res 38:1867\u20131872","journal-title":"Braz J Med Biol Res"},{"key":"3130_CR49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","volume":"2","author":"H Soreq","year":"2001","unstructured":"Soreq H, Seidman S (2001) Acetylcholinesterase\u2014new roles for an old actor. Nat Rev Neurosci 2:294\u2013302","journal-title":"Nat Rev Neurosci"},{"key":"3130_CR50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biocel.2012.11.015","volume":"45","author":"X Zhang","year":"2013","unstructured":"Zhang X, Lu L, Liu S et al (2013) Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson\u2019s disease. Int J Biochem Cell Biol 45:265\u2013272","journal-title":"Int J Biochem Cell Biol"},{"key":"3130_CR51","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","volume":"42","author":"P Lei","year":"2010","unstructured":"Lei P, Ayton S, Finkelstein DI et al (2010) Tau protein: relevance to Parkinson\u2019s disease. Int J Biochem Cell Biol 42:1775\u20131778","journal-title":"Int J Biochem Cell Biol"},{"key":"3130_CR52","first-page":"1","volume":"2014","author":"A Xie","year":"2014","unstructured":"Xie A, Gao J, Xu L, Meng D (2014) Shared mechanisms of neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease. BioMed Res Int 2014:1\u20138","journal-title":"BioMed Res Int"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-020-03130-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:28:56Z","timestamp":1631752136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-020-03130-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3130"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03130-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}